Oncotect has developed a non-invasive, at-home cancer screening test for dogs that utilizes proprietary technology to analyze urine samples for biomarkers associated with the four most common treatable canine cancers. This platform enables early detection of cancer, providing dog owners with a proactive tool to monitor their pets' health and potentially improve treatment outcomes.
Funding
$630K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Canine cancer is a leading cause of death in dogs, with millions diagnosed annually, and late detection often reduces treatment effectiveness. Traditional diagnostic methods can be invasive or may overlook early cancer biomarkers, leading to delayed diagnoses.
Solution
Oncotect offers a non-invasive, at-home urine test that screens for biomarkers associated with the four most common treatable canine cancers: melanoma, lymphoma, mast cell tumor, and hemangiosarcoma. This vet-approved test enables proactive monitoring of a dog's health, facilitating early detection and potentially improving treatment outcomes. Dog owners can conveniently collect a urine sample at home and mail it to Oncotect for analysis, eliminating the need for vet-administered blood draws. The test boasts a 90% accuracy rate, providing reliable results that can inform timely veterinary intervention.
Target Audience
The primary target audience includes dog owners who want to proactively monitor their pet's health for early signs of cancer, as well as veterinarians seeking a convenient and accurate screening tool.
Features
- Non-invasive urine sample collection, eliminating the need for blood draws
- Detects biomarkers associated with melanoma, lymphoma, mast cell tumor, and hemangiosarcoma
- 90% overall accuracy (83% true positive and 96% true negative) based on clinical data
- Results delivered within one week of sample receipt
- Option to easily share results with a veterinarian
- Suitable for dogs of all ages, with increased recommendation for older dogs and breeds with higher cancer risk